CEP41: A Potential Drug Target and Biomarker for Testis-Specific Gene A14 Protein

Target Name: CEP41

NCBI ID: G95681

CEP41

CEP41: A Potential Drug Target and Biomarker for Testis-Specific Gene A14 Protein

Testis-specific gene A14 protein (CEP41) is a key regulator of testicular development and has been implicated in various diseases, including infertility, germ cell dysfunction, and testicular cancer. Its function in these processes makes CEP41 an attractive drug target and a potential biomarker for these diseases. In this article, we will discuss the biology of CEP41, its potential as a drug target, and its potential as a biomarker for testicular diseases.

Biography of CEP41

CEP41 is a 21-kDa transmembrane protein that is expressed in a variety of tissues, including testes, brain, heart, and intestine. It is a member of the TGF-β family and is involved in cell signaling, including TGF-β signaling, which plays a crucial role in the development and maintenance of tissues. CEP41 has been shown to be involved in the regulation of germ cell development, specifically spermatogonial stem cells (SSCs) and germinal villi development.

Potential Drug Target

CEP41 has been identified as a potential drug target due to its involvement in various diseases, including testicular cancer, infertility, and neurodegenerative diseases. Its role in testicular cancer is well established, as CEP41 has been shown to be involved in the regulation of cell proliferation and survival, as well as the development of cancer cells. In addition, CEP41 has also been implicated in the development of infertility, as it has been shown to be involved in the regulation of spermatozoa production and quality.

Potential Biomarker

CEP41 has also been identified as a potential biomarker for a variety of testicular diseases, including testicular cancer, infertility, and neurodegenerative diseases. Its involvement in these diseases makes it an attractive candidate for use as a biomarker for these conditions. For example, as testicular cancer is a leading cause of male infertility, detecting and treating CEP41-related genetic alterations could lead to new therapeutic approaches for this disease. Similarly, its involvement in the regulation of spermatozoa production and quality makes it an attractive candidate for use as a biomarker for infertility.

In conclusion, CEP41 is a gene that has been shown to be involved in a variety of processes, including cell signaling, germ cell development, and tissue regulation. Its potential as a drug target and biomarker for testicular diseases makes it an attractive candidate for further research and development. Further studies are needed to fully understand the role of CEP41 in these diseases and to develop new therapeutic approaches based on its properties.

Protein Name: Centrosomal Protein 41

Functions: Required during ciliogenesis for tubulin glutamylation in cilium. Probably acts by participating in the transport of TTLL6, a tubulin polyglutamylase, between the basal body and the cilium

The "CEP41 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEP41 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets